Minimally invasive biomarker confirms glial activation present in Alzheimer&#39;s disease: a preliminary study

Minimally invasive biomarker confirms glial activation present in Alzheimer&#39;s disease: a preliminary study

Napapon Sailasuta, Kent Harris, Thao Tran, Brian RossClinical MR Unit, Huntington Medical Research Institutes, Pasadena, CA, USAAbstract: We applied 13C magnetic resonance spectroscopy (MRS), a nonradioactive, noninvasive brain imaging technique, to quantify the oxidation of [1-13C] acetate in a con...

Full description

Bibliographic Details
Main Authors:	Tran T, Harris K, Sailasuta N, Ross B
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-08-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/minimally-invasive-biomarker-confirms-glial-activation-present-in-alzh-a8143

Similar Items

Minimally invasive esophagectomy for esophageal cancer in the People&#39;s Republic of China: an overview
by: Zhu C, et al.
Published: (2013-03-01)

Network based biomarkers in Alzheimer's disease: review and future directions
by: Jaime eGomez-Ramirez, et al.
Published: (2014-02-01)

A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients
by: Simona Giglio, et al.
Published: (2021-02-01)

Alzheimer&#39;s disease and primary open-angle glaucoma: is there a connection
by: Tsolaki F, et al.
Published: (2011-06-01)

Pulmonary Kaposi&#39;s Sarcoma - Initial Presentation of HIV Infection&nbsp;
by: Radka Komitova, et al.
Published: (2019-12-01)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
by: Simon-Shlomo ePoil, et al.
Published: (2013-10-01)

Alzheimer's disease and blood-based biomarkers – potential contexts of use
by: Zvěřová M
Published: (2018-07-01)

Advance of glial cells in Alzheimer's disease
by: Fang-Fang Liu, et al.
Published: (2020-12-01)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
by: Hoogveldt B, et al.
Published: (2011-06-01)

Molecular Biomarkers for Diagnosis & Therapies of Alzheimer’s Disease
by: Pravin D Potdar, et al.
Published: (2016-11-01)

Current and future role of biomarkers in Crohn&#39;s disease risk assessment and treatment
by: Tamboli CP, et al.
Published: (2011-06-01)

Biomarkers of Alzheimer's Disease: The Present and the Future
Published: (2016)

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer&#39;s disease
by: Ismail MF, et al.
Published: (2013-01-01)

The genetics of Alzheimer's disease
by: Bagyinszky E, et al.
Published: (2014-04-01)

In vivo Imaging of Glial Activation in Alzheimer's Disease
by: Paul Edison, et al.
Published: (2018-08-01)

Editor&#39;s choice
by: Pinder RM
Published: (2012-07-01)

Editor&#39;s choice
by: S&oslash;rensen HT
Published: (2012-07-01)

A New Precision Minimally Invasive Method of Glial Scar Simulation in the Rat Spinal Cord Using Cryoapplication
by: Georgii B. Telegin, et al.
Published: (2021-07-01)

The Biomarkers for Identifying Preclinical Alzheimer's Disease via Structural and Functional Magnetic Resonance Imaging
by: Yanhong eZhou, et al.
Published: (2016-04-01)

A role for the brain RAS in Alzheimer's and Parkinson's diseases
by: John William Wright, et al.
Published: (2013-10-01)

Preliminary results from minimally invasive video-assisted thyroidectomy
by: Rogério Aparecido Dedivitis, et al.

Glial activation and inflammation along the Alzheimer’s disease continuum
by: Kaja Nordengen, et al.
Published: (2019-02-01)

Epigenetic Alterations in Alzheimer's Disease
by: Johannes eGräff, et al.
Published: (2015-12-01)

Nutrition, Frailty, and Alzheimer's Disease
by: Francesco ePanza, et al.
Published: (2014-08-01)

Nutrition and Prevention of Alzheimer's Disease
by: Claudia ePerez-Cruz, et al.
Published: (2015-09-01)

Corrigendum
by: Sailasuta N, et al.
Published: (2011-11-01)

Neovascularization in Purtscher&#39;s retinopathy
by: Chan A, et al.
Published: (2011-11-01)

If you don&#39;t take it &ndash; it can&#39;t work: the consequences of not being treated or nonadherence to osteoporosis therapy
by: Adachi JD, et al.
Published: (2011-05-01)

Galantamine treatment in Alzheimer&#39;s disease: response and long-term outcome in a routine clinical setting
by: Wallin &Aring;K, et al.
Published: (2011-09-01)

Phospholipids and Alzheimer&#8217;s Disease: Alterations, Mechanisms and Potential Biomarkers
by: Marko Kosicek, et al.
Published: (2013-01-01)

Diagnostic Biomarkers for Alzheimer’s Disease Using Non-Invasive Specimens
by: Maria Paraskevaidi, et al.
Published: (2020-06-01)

The role of glial cells in Alzheimer disease: potential therapeutic implications
by: I. Lopategui Cabezas, et al.
Published: (2014-06-01)

Research on the Glial–Lymphatic System and Its Relationship With Alzheimer’s Disease
by: Danhua Ding, et al.
Published: (2021-06-01)

Electroencephalography-driven approach to prodromal Alzheimer's disease diagnosis: from biomarker integration to network-level comprehension
by: Moretti DV
Published: (2016-07-01)

Rivastigmine in the treatment of Alzheimer's disease: an update
by: Maria Luisa Onor, et al.
Published: (2007-04-01)

Disease-modifying drugs in Alzheimer's disease
by: Ghezzi L, et al.
Published: (2013-12-01)

Beta-amyloidolysis and glutathione in Alzheimer's disease
by: Lasierra-Cirujeda J, et al.
Published: (2013-04-01)

Long noncoding RNAs and Alzheimer's disease
by: Luo Q, et al.
Published: (2016-06-01)

Cognition and dual-task performance in older adults with Parkinson's and Alzheimer's disease
by: Christofoletti G, et al.
Published: (2014-07-01)

Immunohistochemical Localization of CDK5 Activator p39 in the Rat Brain and p39-immunoreactivity in Glial Cytoplasmic Inclusions in Brains with Multiple System Atrophy.
by: Honjo, Yasuyuki
Published: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lnl329gfnm3603j54lc2np3q1m